Robotic knee surgery platform developer OmniLife Science said today it began testing on its OmniBotics active spacer robotic tissue balancing device at 3 US sites after having won FDA 510(k) clearance in September. The Raynham, Mass.based company said its OmniBotics active spacer is designed to allow surgeons performing total knee surgeries to quantitatively manage the…
OMNIlife science tissue balancing tool receives FDA clearance
The FDA gave 501(k) clearance for a robotic tissue balancing device from OMNIlife science, which works with its OMNIBotics robotic-assisted knee replacement technology to provide a more custom procedure. The tool monitors the soft tissue envelope during an operation and provides feedback to the surgeon in real time. Using it in coordination with the OMNIBotics…